Holen Sie sich die Stockscreener-App
9.14
1.51%
-0.14
Handel nachbörslich:
3.43
-5.71
-62.47%
Schlusskurs vom Vortag:
$9.28
Offen:
$9.22
24-Stunden-Volumen:
1.67M
Relative Volume:
2.44
Marktkapitalisierung:
$1.34B
Einnahmen:
$340.46M
Nettoeinkommen (Verlust:
$98.11M
KGV:
-52.35
EPS:
-0.1746
Netto-Cashflow:
$43.17M
1W Leistung:
+19.63%
1M Leistung:
+57.04%
6M Leistung:
+17.18%
1J Leistung:
+29.46%
1-Tages-Spanne:
$8.94
$9.49
1-Wochen-Bereich:
$7.325
$9.49
52-Wochen-Spanne:
$5.47
$9.49
Mimedx Group Inc Stock (MDXG) Company Profile
Firmenname
Mimedx Group Inc
Sektor
Branche
Telefon
(770) 651-9100
Adresse
1775 W OAK COMMONS COURT, NE, MARIETTA
Vergleichen Sie MDXG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| MDXG | 6.49 | 0 | 0 | 0 | 0 | 0.00 |
| GOODO | 22.16 | 372.90M | 0 | 0 | 0 | 0.00 |
| PSNYW | 0.141 | 297.56M | 2.07B | -1.42B | -1.37B | -0.1344 |
| MOBBW | 0.16 | 278.60M | 0 | 0 | 0 | 0.00 |
| SHMD | 2.61 | 114.98M | 0 | 0 | 0 | 0.00 |
| JUNE | 4.95 | 63.87M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-07 | Eingeleitet | Lake Street | Buy |
| 2023-10-27 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-07-26 | Eingeleitet | Northland Capital | Outperform |
| 2021-03-19 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Mimedx Group Inc Aktie (MDXG) Neueste Nachrichten
MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year HighHere's Why - MarketBeat
Mizuho increases MiMedx stock target, rating held on Medicare decision - Investing.com
Mizuho increases MiMedx stock target, rating held on Medicare decision By Investing.com - Investing.com Canada
MiMedx stock soars to 52-week high, touches $9.28 - Investing.com India
MiMedx stock soars to 52-week high, touches $9.28 By Investing.com - Investing.com Canada
MiMedx Group (NASDAQ:MDXG) Shares Gap UpShould You Buy? - MarketBeat
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for - GlobeNewswire
MIMEDX Products Secure Medicare Coverage as 200+ Competitors Cut from 2025 LCD Update | MDXG Stock News - StockTitan
Analysts Set MiMedx Group, Inc. (NASDAQ:MDXG) Price Target at $12.00 - MarketBeat
MiMedx Group (NASDAQ:MDXG) Downgraded to Buy Rating by StockNews.com - MarketBeat
Trigran Investments, Inc. Expands Stake in MiMedx Group Inc - GuruFocus.com
MiMedx Group's (NASDAQ:MDXG) Promising Earnings May Rest On Soft Foundations - Yahoo Finance
There's No Escaping MiMedx Group, Inc.'s (NASDAQ:MDXG) Muted Earnings Despite A 27% Share Price Rise - Simply Wall St
MIMEDX Group's SWOT analysis: wound care firm's stock faces market headwinds - Investing.com
Vanguard Group Inc's Strategic Acquisition in MiMedx Group Inc - GuruFocus.com
MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Harbor Capital Advisors Inc. - MarketBeat
Northland Capmk Expects Increased Earnings for MiMedx Group - MarketBeat
MiMedx Group Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2024 Earnings Call Transcript - Insider Monkey
Possible Signal As MiMedx Group Insiders Sell US$659k In Stock - Simply Wall St
Earnings call: MiMedx reports growth and optimism amidst challenges - Investing.com
Earnings call: MiMedx reports growth and optimism amidst challenges By Investing.com - Investing.com UK
MiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong - GuruFocus.com
MiMedx: Q3 Earnings Snapshot - Milford Mirror
MiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong International Growth and New ... - Yahoo Finance
MiMedx Group Inc. Reports Q3 2024 Financial Results - TipRanks
MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
MIMEDX Announces Third Quarter 2024 Operating and Financial Results - The Manila Times
MiMedx Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MiMedx Group (MDXG) to Release Quarterly Earnings on Wednesday - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
MiMedx Group (NASDAQ:MDXG) Lowered to "Buy" at StockNews.com - MarketBeat
MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 - GlobeNewswire
Cubist Systematic Strategies LLC Cuts Stake in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
Learn to Evaluate (MDXG) using the Charts - Stock Traders Daily
Millennium Management LLC Grows Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Millennium Management LLC Increases Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx finds itself in legal tussles with FDA and ex-employees - The Atlanta Journal Constitution
MiMedx stock touches 52-week low at $5.56 amid market challenges By Investing.com - Investing.com South Africa
MiMedx Group Inc (MDXG) Q2 2024 Earnings Call Highlights: Strong Sales Growth Amid Market Challenges - Investing.com Canada
MiMedx stock touches 52-week low at $5.56 amid market challenges - Investing.com
MiMedx Group (NASDAQ:MDXG) Reaches New 12-Month LowWhat's Next? - MarketBeat
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue - ForexTV.com
MDXGMiMedx Group, Inc Latest Stock News & Market Updates - StockTitan
Finanzdaten der Mimedx Group Inc-Aktie (MDXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):